CD244 represents a new therapeutic target in head and neck squamous cell carcinomaLaura Agresta, Edith M. Janssen, Maria Lehn et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 54
PD1 blockade enhances K<sup>+</sup> channel activity, Ca<sup>2+</sup> signaling, and migratory ability in cytotoxic T lymphocytes of patients with head and neck cancerHannah S. Newton, Laura Conforti, Sarah Palackdharry et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 33
Proton Treatment Suppresses Exosome Production in Head and Neck Squamous Cell CarcinomaAmeet A. Chimote, Laura Conforti, Maria Lehn et al.|Cancers|2024Cited by 7
Pembrolizumab treatment increases K+ channel function and calcium fluxes in cytotoxic T cells of head and neck cancer patientsHannah S. Newton, Laura Conforti, Vaibhavkumar S. Gawali et al.|The Journal of Immunology|2020Cited by 0
Proton therapy inhibits the production of immune suppressive exosomes in head and neck squamous cell carcinomaAmeet A. Chimote, Laura Conforti, Maria Lehn et al.|The Journal of Immunology|2024Cited by 0